Association between Pro12Ala and His477His polymorphisms in PPARG gene and insulin resistance in patients with polycystic ovary syndrome;Udruženost polimorfizama Pro12Ala i His477His gena PPARG s inzulinskom rezistencijom u bolesnica sa sindromom policističnih jajnika

Biochemia Medica

Volumn 18, Issue 3, 2008, Pages 342-350

  Dragojević, Jana ^a   Marc, Janja ^a   Mlinar, Barbara ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

hsCRP; Insulin resistance; PCOS; Polymorphism; PPAR

Indexed keywords

ALANINE; C REACTIVE PROTEIN; GLUCOSE; HISTIDINE; INSULIN; PROLINE;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PILOT STUDY; POLYMERASE CHAIN REACTION; PPARG GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSCRIPTION REGULATION;

EID: 54349105475     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/bm.2008.030     Document Type: Article

References (27)

1. Mlinar B, Marc J, Janež A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 2007;375:20-35.
2. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 2005;26:251-82.
3. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004:53:S43-S50.
4. Cock TA, Houten SM, Auwerx J. Peroxisome proliferator-activated receptor-γ: too much of a good thing causes harm. EMBO Rep 2004;5:142-7.
5. Knouff C, Auwerx J. Peroxisome proliferator-activated receptor-γ calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev 2004;25:899-918.
6. Merihaeghe A, Fajas L, Gouilleux F, Cottel D, Helbecque N, Auwerx J, et al. A functional polymorphism in a STAT5B site of the human PPARγ3 gene promoter affects height and lipid metabolism in a French population. Arterioscler Thromb Vasc Biol 2003;23:289-94.
7. Meirhaeghe A, Amouyel P. Impact of genetic variation of PPARγ in humans. Mol Genet Metab 2004;83:93-102.
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9.
9. Globočnik Petrovič M, Kunej T, Peterlin B, Dovč P, Petrovič D. Gly482-Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of PPARγ gene is not. Diabetes Met Res Rev 2005;21:470-4.
10. Court lab - HW calculator. Court MH. Available at: www.tufts.edu/ ~mcourt01/Documents/Court%20lab%20-%20HW%20calculator.xls Accessed Jul 23th 2008.
11. Ding K, Zhou K, He F, Shen Y. LDA - a java-based linkage disequilibrium analyzer. Bioinformatics 2003;19:2147-8.
12. Halperin E, Eskin E. Haplotype reconstruction from genotype data using imperfect phylogeny. Bioinformatics 2004;20:1842-9.
13. Frederiksen L, Brødbæk K, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad SM, et al. Studies of the Pro12Ala polymorphism of the PPA-Rγ gene in the Danish MONICA cohort: homozygosity of the G allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 2002;87:3989-92.
14. Doney A, Fischer B, Frew D, Cumming A, Flavell D, World M, et al. Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet 2002;3:21.
15. Doney ASF, Fischer B, Cecil JE, Boylan K, McGuigan FE, Ralston SH, et al. Association of the Pro12Ala and C1431T variants of PPARG and their susceptibility to type 2 diabetes. Diabetologia 2004;47:555-8.
16. Valve R, Sivenius K, Miettinen R, Pihlajamaki J, Rissanen A, Deeb SS, et al. Two polymorphisms in the peroxisome proliferator-activated receptor-7 gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999;84:3708-12.
17. Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J. Association between PPARγ haplotypes and the metabolic syndrome in French men and women. Diabetes 2005;54:3043-8.
18. Tai SE, Corella D, Deurenberg-Yap M, Adicons X, Chew SK, Tan CE, et al. Differential effects of the C1431T and Pro12Ala PPARγ gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res 2004;45:674-85.
19. Wei Q, Jacobs DR, Schreiner PJ, Siscovick DS, Stedes MW, Fornage M. Patterns of association between PPARγ genetic variation and indices of adiposity and insulin action in African-Americans and whites: the CARDIA Study. J Mol Med 2006;84:955-65.
20. Hara M, Alcoser SZ, Qaadir A, Beiswenger KK, Cox NJ, Ehrmann DA. Insulin resis tance is attenuated in women with polycystic ovary syndrome with the Pro12Ala polymorphism in the PPARγ gene. J Clin Endocrinol Metab 2002;87:772-5.
21. Kang SE, Park SY, Kim HJ, Kim SC, Ahn CW, Cha BS, et al. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes. Clin Pharmacol Ther 2005;78:202-8.
22. Orio F Jr, Matarese G, Di Biase S, Palomba S, Labella D, Sanna V, et al. Exon 6 and 2 peroxisome proliferator-activated receptor-γ polymorphisms in polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:5887-92.
23. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville P, et al. A genetic polymorphism of the peroxisome proliferato r-activated receptor γ gene influences plasma leptin levels in obese humans. Hum Mol Gen 1998;7:435-40.
24. Wang XL, Oosterhof J, Duarte N. Peroxisome proliferator-activated receptor gamma C161→T polymorphism and coronary artery disease. Cardiovasc Res 1999;44:588-94.
25. Orio F Jr, Palomba S, Cascella T, Di Biase S, Labella D, Russo T, et al. Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J Clin Endocrinol Metab 2004;89:5110-5.
26. Masud S, Ye S. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 2003;40:773-80.
27. Tönjes A, Scholz M, Loeter M, Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 2006;29:2489-97.